Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Longitude Rx is a health system-owned specialty pharmacy services organization established in 2024 by a consortium of leading U.S. health systems, including Baylor Scott & White Health, Memorial Hermann Health System, Michigan Medicine, Novant Health, and Providence. The company provides a unified, data-driven platform designed to help health systems optimize their specialty pharmacy operations, improve patient access and adherence to complex therapies, and capture specialty pharmacy revenue. By integrating advanced technology, such as the Innovaccer Gravity platform, with clinical and operational expertise, Longitude Rx streamlines workflows for prior authorization, 340B compliance, and patient engagement. It serves as a strategic partner for health systems to manage high-cost medications, including cell and gene therapies, while ensuring seamless care coordination and improved clinical outcomes. The organization aims to transform the specialty pharmacy landscape by aligning pharmacy operations directly with health system goals and community needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Longitude Rx.